The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Furthering cell therapy ambition across oncology and autoimmune diseases
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
World HRD Congress is a well-known international body of Management Studies
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Subscribe To Our Newsletter & Stay Updated
